IL23A and neoplasm: In conclusion, we found that IL-23, an immunological cytokine upregulated by chemotherapy in TNBC cells, plays a vital role in enhancing the anti-tumor immune response of cytotoxic T cells (CTLs), especially in combination with PD-1 mAb.